title: Response letter regarding the letter to the editors by Butt et al. Does it matter Discounting and its role in the cost-effectiveness of preventative interventions. The case of HPV vaccination.
authors.affiliation: GSK, London, UK. Electronic address: helen.j.starkie-camejo@gsk.com.
authors.forename: Helen
authors.initials: H
authors.lastname: Starkie Camejo
authors.affiliation: GSK Vaccines, Wavre, Belgium.
authors.forename: X
authors.initials: X
authors.lastname: Li
authors.affiliation: GSK Vaccines, Wavre, Belgium.
authors.forename: G
authors.initials: G
authors.lastname: Van Kriekinge
authors.affiliation: GSK Vaccines, Wavre, Belgium.
authors.forename: M
authors.initials: M
authors.lastname: Ryser
mesh_terms: D003362:Cost-Benefit Analysis / Q000379:methods*; D055088:Early Detection of Cancer / Q000191:economics*; D005260:Female; D006801:Humans; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000191:economics*; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control*
chemical_list: D053918:Papillomavirus Vaccines